Skip to content

Multi-parametric Functional MRI in Patients of Chronic Kidney Disease

Quantitative Mapping Based on Multi-parametric Functional MRI to Evaluate Renal Functions and Microstructure in Chronic Kidney Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06639685
Enrollment
200
Registered
2024-10-15
Start date
2024-10-01
Completion date
2025-12-31
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease(CKD), MRI

Keywords

Chronic Kidney Disease, MR Fingerprinting, ASL

Brief summary

To explore the value of MR Fingerprinting-generated quantitative maps combined with ASL renal perfusion imaging in the assessment of renal impairment in chronic kidney disease.

Detailed description

Chronic kidney disease (CKD) has become an important public health problem threatening human health worldwide. The prevalence rate of CKD in Chinese adults is 10.8%, but the awareness rate and diagnosis rate are generally low. At present, the assessment of renal impairment in CKD mainly relies on laboratory tests, such as estimated glomerular filtration rate (eGFR) and urinary protein/creatinine ratio, and the value of functional MRI in the assessment of renal impairment in patients with CKD is unclear. As a new sequence still in the scientific research stage, MR Fingerprinting can simultaneously generate quantitative T1 maps, T2 maps and proton-weighted images in one breath holding scan, with short scanning time, high repeatability and accuracy. It has been proved that quantitative techniques of T1 mapping and T2 mapping are valuable for evaluating the degree of renal fibrosis and water content. Kidney is a blood-rich organ, and the blood flow of kidney is of great significance to the evaluation of renal function. ASL uses hydrogen protons in arterial blood as an endogenous tracer to evaluate tissue blood perfusion, and can quantitatively evaluate renal blood perfusion in patients with CKD without the use of exogenous contrast agents, avoiding the risk of aggravated renal damage and nephrogenic fibrosis caused by injection of gadoline-containing contrast agents. The objective of our study was to explore the value of MRF sequence-generated quantitative maps combined with ASL renal perfusion imaging in the assessment of renal impairment in chronic kidney disease.

Interventions

DIAGNOSTIC_TESTMRI

MR Fingerprinting and ASL

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with chronic kidney disease (CKD) by renal biopsy

Exclusion criteria

* Patients with serious underlying diseases * Patients with MRI incompatible metal implants and contraindications such as claustrophobia * Patients with imperfect clinical data and pathological data

Design outcomes

Primary

MeasureTime frameDescription
T1 and T2 value3 monthsT1 and T2 value generated by MR Fingerprinting

Countries

China

Contacts

Primary ContactYu dong Zhang, MD,PHD
zhangyd3895@njmu.edu.cn+86 158-0515-1704
Backup ContactShuai Shan
njmu_ss@stu.njmu.edu.cn+86 198-5092-2832

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026